Abstract: A method and apparatus for automatically determining that delivery of an untagged item occurred are described. Data is received, from a gateway device located on a vehicle on which the untagged item is transported, where the data includes data collected by the gateway device from a set of devices external to the gateway device. A determination of whether the vehicle stopped is performed based on a first part of the data pertaining to the movement of the vehicle. Automatic determination of whether offload of cargo from the vehicle occurred, is performed based on a second part of the data, which is consistent with activity indicative of the offload of cargo from the vehicle as opposed to data collected based on a tag on an item. Responsive to determining that the offload of cargo from the vehicle occurred, a report including information to be used as proof of delivery is transmitted.

Abstract: Some embodiments of the present invention include a method for processing entities and may include generating, by a computing system, a hierarchical structure representation of entities from a plurality of entities of an object; receiving, by the computing system, information about a current entity; displaying, by the computing system, the current entity and a number of entities related to the current entity using the hierarchical structure representation of the entities, the number of related entities displayed being based on a display range; and updating, by the computing system, the display of the current entity and the related entities based on detecting a scrolling up action on a graphical user interface associated with the computing system.

Abstract: Clear bioavailable liquid softgel fill compositions comprising a) at least one analgesic and one or more of decongestants, expectorants, antitussives and/or antihistamines; b) a matrix comprising a pharmaceutically acceptable poly(alkylene glycol) and a pharmaceutically acceptable alkylene glycol; c) a solubilizing agent comprising a pharmaceutically acceptable polymeric solubilizing agent and water are disclosed. Also disclosed are methods for the preparation of such clear fill compositions, and softgel capsules containing the clear bioavailable liquid fill composition.

Abstract: Bioavailable liquid softgel fill compositions comprising a) fexofenadine or a fexofenadine salt; b) a matrix comprising a pharmaceutically acceptable poly(alkylene glycol), optionally a pharmaceutically acceptable alkylene glycol, optionally a pharmaceutically acceptable polymeric solubilizing agent, and optionally a pharmaceutically acceptable surfactant; and c) a pharmaceutically acceptable acidulant are disclosed. Also disclosed are methods for the preparation of such fill compositions, and softgel capsules containing the bioavailable liquid fill composition.

Abstract: Stabilized liquid, suspension or gel compositions containing a dialkyl fumarate and comprising a vehicle which serves as a protective base, a pharmaceutically acceptable surfactant, and a pharmaceutically acceptable acidulant, and methods of preparing such compositions are disclosed. Capsules and other dosage forms containing the stabilized liquid, suspension or gel compositions are also disclosed.

Abstract: Bioavailable liquid softgel fill compositions comprising a) fexofenadine or a fexofenadine salt; b) a matrix comprising a pharmaceutically acceptable poly(alkylene glycol), a pharmaceutically acceptable alkylene glycol, a pharmaceutically acceptable polymeric solubilizing agent, and a pharmaceutically acceptable surfactant; and c) a pharmaceutically acceptable acidulant are disclosed. Also disclosed are methods for the preparation of such fill compositions, and softgel capsules containing the bioavailable liquid fill composition.

Abstract: A pharmaceutical formulation contains 10-60% by weight acetaminophen as the only active ingredient and a solvent system for dissolving the acetaminophen. The formulation is free of any ionizing agent and its solvent system includes water, polyethylene glycol, and polyvinylpyrrolidone that is 2-50% by weight and has a molecular weight of 2,000 to 1,500,000. Also disclosed is another acetaminophen formulation containing polyvinylpyrrolidone as high as 25-50% by weight.

Abstract: A pharmaceutical formulation contains 10-60% by weight acetaminophen as the only active ingredient and a solvent system for dissolving the acetaminophen. The formulation is free of any ionizing agent and its solvent system includes water, polyethylene glycol, and polyvinylpyrrolidone that is 2-50% by weight and has a molecular weight of 2,000 to 1,500,000. Also disclosed is another acetaminophen formulation containing polyvinylpyrrolidone as high as 25-50% by weight.

Abstract: A method and system are provided which receive information from a non-standard source, in a relatively standardized manner. The received information is operated upon using an artificial intelligence module to translate the received information into a standardized internet protocol, such as XML (extensible Mark-Up Language).